ATEC
Price
$15.20
Change
-$0.14 (-0.91%)
Updated
Aug 6 closing price
Capitalization
1.9B
84 days until earnings call
BIO
Price
$272.18
Change
-$0.00 (-0.00%)
Updated
Aug 6 closing price
Capitalization
9.79B
77 days until earnings call
Interact to see
Advertisement

ATEC vs BIO

Header iconATEC vs BIO Comparison
Open Charts ATEC vs BIOBanner chart's image
Alphatec Holdings
Price$15.20
Change-$0.14 (-0.91%)
Volume$4.37M
Capitalization1.9B
Bio-Rad Laboratories
Price$272.18
Change-$0.00 (-0.00%)
Volume$2.58K
Capitalization9.79B
ATEC vs BIO Comparison Chart in %
Loading...
ATEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATEC vs. BIO commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATEC is a Buy and BIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (ATEC: $15.20 vs. BIO: $264.32)
Brand notoriety: ATEC and BIO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ATEC: 196% vs. BIO: 96%
Market capitalization -- ATEC: $1.9B vs. BIO: $9.79B
ATEC [@Medical Specialties] is valued at $1.9B. BIO’s [@Medical Specialties] market capitalization is $9.79B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATEC’s FA Score shows that 0 FA rating(s) are green whileBIO’s FA Score has 0 green FA rating(s).

  • ATEC’s FA Score: 0 green, 5 red.
  • BIO’s FA Score: 0 green, 5 red.
According to our system of comparison, ATEC is a better buy in the long-term than BIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATEC’s TA Score shows that 5 TA indicator(s) are bullish while BIO’s TA Score has 4 bullish TA indicator(s).

  • ATEC’s TA Score: 5 bullish, 4 bearish.
  • BIO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ATEC is a better buy in the short-term than BIO.

Price Growth

ATEC (@Medical Specialties) experienced а +41.66% price change this week, while BIO (@Medical Specialties) price change was +5.69% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.86%. For the same industry, the average monthly price growth was -0.52%, and the average quarterly price growth was -2.90%.

Reported Earning Dates

ATEC is expected to report earnings on Oct 30, 2025.

BIO is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Medical Specialties (-0.86% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIO($9.79B) has a higher market cap than ATEC($1.9B). ATEC YTD gains are higher at: 65.577 vs. BIO (-19.540). ATEC has higher annual earnings (EBITDA): -110.59M vs. BIO (-654.76M). BIO has more cash in the bank: 1.61B vs. ATEC (221M). ATEC has less debt than BIO: ATEC (542M) vs BIO (1.41B). BIO has higher revenues than ATEC: BIO (2.67B) vs ATEC (482M).
ATECBIOATEC / BIO
Capitalization1.9B9.79B19%
EBITDA-110.59M-654.76M17%
Gain YTD65.577-19.540-336%
P/E RatioN/A3.64-
Revenue482M2.67B18%
Total Cash221M1.61B14%
Total Debt542M1.41B39%
FUNDAMENTALS RATINGS
ATEC vs BIO: Fundamental Ratings
ATEC
BIO
OUTLOOK RATING
1..100
1864
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
51100
SMR RATING
1..100
10085
PRICE GROWTH RATING
1..100
3754
P/E GROWTH RATING
1..100
10062
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIO's Valuation (85) in the Medical Specialties industry is in the same range as ATEC (99). This means that BIO’s stock grew similarly to ATEC’s over the last 12 months.

ATEC's Profit vs Risk Rating (51) in the Medical Specialties industry is somewhat better than the same rating for BIO (100). This means that ATEC’s stock grew somewhat faster than BIO’s over the last 12 months.

BIO's SMR Rating (85) in the Medical Specialties industry is in the same range as ATEC (100). This means that BIO’s stock grew similarly to ATEC’s over the last 12 months.

ATEC's Price Growth Rating (37) in the Medical Specialties industry is in the same range as BIO (54). This means that ATEC’s stock grew similarly to BIO’s over the last 12 months.

BIO's P/E Growth Rating (62) in the Medical Specialties industry is somewhat better than the same rating for ATEC (100). This means that BIO’s stock grew somewhat faster than ATEC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATECBIO
RSI
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
63%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
69%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
65%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
69%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 13 days ago
67%
Declines
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 1 day ago
67%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
ATEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTADX55.40N/A
N/A
Fidelity Advisor International Discv M
HWSIX73.01N/A
N/A
Hotchkis & Wiley Small Cap Value I
NMUCX10.24N/A
N/A
Neuberger Berman Multi-Cap Opp C
FGKMX132.20N/A
N/A
Fidelity Advisor Communication ServicesZ
FEMAX11.67N/A
N/A
First Eagle U.S. SMID Cap Opportunity A

ATEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATEC has been loosely correlated with LAB. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ATEC jumps, then LAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATEC
1D Price
Change %
ATEC100%
-0.91%
LAB - ATEC
40%
Loosely correlated
-1.54%
TFX - ATEC
36%
Loosely correlated
-2.42%
BIO - ATEC
35%
Loosely correlated
-2.89%
NVST - ATEC
35%
Loosely correlated
-1.79%
MYGN - ATEC
33%
Loosely correlated
+46.51%
More